The issue at the center of this recall, which includes both the HeartMate II and HeartMate 3 LVAD, is the gradual buildup of biological materials. This can impact the device's performance, creating a heightened risk of injury or death.
As part of its drive to balance the budget, ACR also is reviewing “all programs and areas for potential savings," leaders told attendees at the organization's annual meeting.
The new data highlight a potential pitfall of unenhanced CT scans on patients presenting to emergency departments with acute pain—an inaccurate workup.
Hospitals need to do their homework when it comes to which solution is best for them, Pure Storage's Josh Gluck told Radiology Business at the HIMSS23 meeting.
